key: cord-0745103-03jjrioy authors: Rader, Benjamin; Astley, Christina M; Sy, Karla Therese L; Sewalk, Kara; Hswen, Yulin; Brownstein, John S; Kraemer, Moritz U G title: Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates date: 2020-05-15 journal: J Travel Med DOI: 10.1093/jtm/taaa076 sha: 611387b274353b4e27c3f195a43a0ba66287d4be doc_id: 745103 cord_uid: 03jjrioy We paired high-resolution travel-time metrics with a SARS-CoV-2 testing location database in the United States. Median travel time to testing sites is longer in counties with lower population density, and a higher percent of minority and uninsured individuals. Differential geographic accessibility to testing can recapitulate healthcare disparities and bias transmission estimates. We paired high-resolution travel-time metrics with a SARS-CoV-2 testing location database in the United States. Median travel time to testing sites is longer in counties with lower population density, and a higher percent of minority and uninsured individuals. Differential geographic accessibility to testing can recapitulate healthcare disparities and bias transmission estimates. Uniform access to SARS-CoV-2 testing is crucial for controlling the COVID-19 epidemic 1 Inequalities in geographic accessibility to healthcare in the US have been documented to cause negative health outcomes for seasonal influenza transmission and other diseases 4 . Further, travel time negatively impacts healthcare-seeking behavior 5 . The deployment of SARS-CoV-2 testing within existing medical infrastructure, while logistically efficient, may exacerbate this disparity in health outcomes 6 and underestimate disease burden in disadvantaged populations. Geographic accessibility to SARS-CoV-2 testing sites, to our knowledge, has not been systematically quantified. Therefore, we evaluated whether testing sites were equally accessible to populations across the US, leveraging two public SARS-CoV-2 testing site datasets and a high-resolution map of travel times. Figure 1) . The travel time from each 1 km 2 grid cell to the nearest US testing site is spatially heterogeneous at the national and state level (Figure 1A, 1B and 1C) . Thirty percent of the population live in a county (N = 1,920) with a median travel time over 20 minutes, though with pronounced regional differences ( Figure 1D ) ranging from 5% to 86%. Population density, a determinant of population distribution, was associated with a shorter median county-level travel time ( Table 2) . While controlling for population density as a potential confounder, percent minority was associated with an increase in travel time, as was percent uninsured. These associations remained when also adjusting for median income. We found a significant negative interaction between percent uninsured and population density (p<0.01) suggesting that the disparity of longer rural travel times is greater in counties where a higher proportion of the population is uninsured. Percent minority and population density did not interact statistically. Using two large, national datasets of SARS-CoV-2 testing sites paired with estimates of travel times, we demonstrate an uneven distribution of critical public health resources. The testing site distribution recapitulates structural disparities, including inequities among minority, uninsured, and rural groups, which may further perpetuate disparities as the pandemic progresses. Differential accessibility to testing may lead to biases in estimation of disease incidence and potentially delay identification of COVID-19 hot spots. In the absence of representative testing, syndromic surveillance tools may provide early warning signals, and augment targeted-testing and other public health interventions. Despite efforts to ensure comprehensiveness, in some regions our dataset may be missing testing sites (e.g. West Virginia). While some additional testing sites have been created, given recent difficulties scaling up, we believe our database remains representative 9 . There remains potential for differential missingness of sites in areas with reduced "webscraping" visibility or sites specifically placed to address inaccessibility. Nevertheless, this work highlights the need for comprehensive resources and the utility of data sharing during a pandemic. The travel time metric used here accounts for the presence of public transportation and routine traffic. Early evidence shows widespread variability in mobility reductions during the epidemic 10 . Our estimates of differential access present a conservative picture of inequality in the US which may be worse if public transit closures and private transportation were also modeled. Additionally, our models do not examine other, non-geographic barriers to SARS-CoV-2 testing access (e.g. economic), nor geography for residents in Alaska and Hawaii. Travel time, for example, is shorter for urban uninsured minority groups, and therefore does not explain the below average testing rates in disadvantaged urban areas (e.g. Philadelphia). In summary, reduced geographic access to SARS-CoV-2 testing sites is associated with sociodemographic factors that, in turn, are linked to poor structural access to care and health outcomes. The location of future testing sites should explicitly account for travel time and sociodemographic predictors, in addition to other public health testing requirements. 2020:1-29. https://uploadsssl.webflow.com/5c9104426f6f88ac129ef3d2/5e8374ee75221201609ab586_Assessing_m obility_changes_in_the_United_States_during_the_COVID_19_outbreak.pdf. Defining the Epidemiology of Covid-19 -Studies Needed Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) The United States badly bungled coronavirus testing-but things may soon improve Health inequities in influenza transmission and surveillance National and sub-national variation in patterns of febrile case management in sub-Saharan Africa COVID-19 and African Americans A global map of travel time to cities to assess inequalities in accessibility in 2015 Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response Despite Promises, Testing Delays Leave Americans 'Flying Blind' -The Assessing changes in commuting and individual mobility in major metropolitan areas in the United States during the COVID-19 outbreak The funding bodies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. All authors have seen and approved the manuscript